Viewing Study NCT05911061


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-27 @ 7:28 AM
Study NCT ID: NCT05911061
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-25
First Post: 2023-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Sponsor:
Organization: